In this heterogenous but contemporary PAH cohort, we were able to confirm the predictive value of recognized clinical variables such as 6MWD, WHO functional class, and NT-proBNP levels [1], and additionally identify less established variables like renal impairment and DLCO as predictors for adverse outcome in PAH. Here, NPPB is linked to pulmonary arterial hypertension.